InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Martin Patricia A.. Director active across 2 companies, notably AN2 Therapeutics, Inc.. In total, 8 reports have been published. History available since 19 December 2024. The latest transaction was filed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Martin Patricia A. is a declarant linked to AN2 Therapeutics, Inc., where the listed role is Director. The record shows 4 filings in total, and the 4 sampled filings span from 2024-12-23 to 2026-04-10, with the transaction nature listed as Attribution and buy and sell amounts of 0.